Skip to main content
Caplight Logo









Cenexum Technologies

Cenexum Technologies

Private
DenmarkHealthcare & Life Scienceshttps://cenexum.com/

Last Round

Grant

May 8, 2025

Total Funding Raised

$2.61M

Company Overview

Cenexum Technologies is a biotechnology company developing wirelessly powered neural interfacing technology for bi-directional communication with nerve tissue to treat neurological and psychiatric illnesses.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Health IoT, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

neuromodulationneural interfacebrain-computer interfaceBCIimplantable medical deviceclosed-loop stimulationbio-inspired electronicsneurotechbattery-free implantwireless power transferchronic pain treatmentepilepsy treatmentmovement disorder therapyon-device AIbioelectronics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cenexum Technologies Comparables

Compare Cenexum Technologies with similar companies based on industry and business-model similarity.

Cenexum Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Motif Neurotech
83%
ni2o, Inc.
83%
Starfish Neuroscience
82%

Cenexum Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 8, 2025
GrantNov 5, 2024
StrategicNov 29, 2023

Key People

Founding team and executive leadership

Lasse Richter Petersen

Co-founder & Chief Business Officer

Founding Team

Dennis Henriksen

Chief Executive Officer

Executive Team

Cenexum Technologies Investors

Notable investors and investment history

Cenexum Technologies investors
InvestorRounds
Innovation Fund DenmarkGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 8, 2025

    Secured $2.54M from Innovation Fund Denmark.

  • Nov 5, 2024

    $70K grant received from Innovation Fund Denmark.

Cenexum Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cenexum Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cenexum Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersDenmark
Employee Range7
Year Founded2022
Last FundingMay 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?